Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on metal free. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Overcome chiral resolution challenges in Niraparib manufacturing. New metal-free synthesis achieves 97.51% purity with 26.75% overall yield. Reduce equipment costs and supply chain risks.
Discover a cost-effective, catalyst-free route to 5-chloro-3-hydroxy-3-difluoroalkyl-indolin-2-one with >99% yield. Eliminate metal contamination risks and scale up efficiently for pharmaceutical intermediates.
Discover a metal-free, scalable synthesis for trifluoromethylated chromanes. Eliminate transition metal residues and reduce production costs. Contact us for GMP-compliant manufacturing.
Discover a cost-effective, metal-free method for synthesizing tetrahydropyrrole intermediates with >90% yield. Eliminate supply chain risks and reduce waste in your API production.
Overcome moisture sensitivity and noble metal dependency in pyrimidine synthesis. Achieve 50-86% yields with simplified 3-step process for stable API supply chains.
Overcome costly noble metal catalysts and moisture-sensitive steps in pyrimidine synthesis. Discover scalable, high-yield routes for pharmaceutical intermediates.
Eliminate expensive catalysts and harsh conditions in aryltrimethylstannane production. 95% yields, metal-free process, and scalable manufacturing for pharmaceutical intermediates.
Solve low yield and environmental issues in bis(3-amino-4-hydroxyphenyl)hexafluoropropane production. Our CDMO expertise delivers high-purity, scalable synthesis for aerospace and pharmaceutical applications.
Discover how TEMPO/TBN catalysis enables room-temperature N-alkylation with 83% yield, eliminating oxidation agents and reducing supply chain risks for pharmaceutical intermediates.
Solve high-cost Pd-catalyzed synthesis challenges with green supercritical CO2 method. Achieve 55% yield, 99% purity, and simplified separation for bis-ferrocenyl pyridine derivatives. Reduce supply chain risks.
Avoid toxic azides and metal catalysts in 1,2,3-triazole synthesis. Our metal-free route offers high yields (58-83%) and simplified scale-up for API manufacturing.
Eliminate toxic reagents and noble metals in tetracyclic quinazolinone production with 83% yield. Scale to 100MT/yr with NINGBO INNO PHARMCHEM's CDMO expertise.
Solve C-H activation challenges in pharmaceutical intermediates with green protonic acid catalysis. 91% yield, no precious metals, and industrial scalability for R&D and procurement teams.
Solve low-yield challenges in Balasubramide synthesis. 97% ee, 45% yield, no cytotoxicity. CDMO expertise for scalable production.
Discover metal-free visible light catalysis for 3-(2-pyridine) substituted pyrrole synthesis. Achieve 83-96% yields, eliminate heavy metal risks, and optimize your pharmaceutical supply chain.
Solve ASC-J9 supply chain challenges with 95% yield, 98.6% purity, and 3h reaction time. CDMO expertise for pharma scale.
Solve high-cost synthesis challenges with this air-ambient, metal-free method for trifluoroacetimide dihydrobenzofuran. Achieve >99% purity and scalable production for pharma intermediates.
Discover the breakthrough in spirooxindole synthesis with high yield and anti-tumor activity. Optimize your drug development process with this efficient method.
Solve metal residue issues in 3-thioindole production with metal-free photocatalysis. Achieve 70% yield, simplified process, and GMP compliance for your drug development projects.
Solve green chemistry challenges in CF3-introduction with metal-free electrochemical synthesis. High yields, no toxic reagents, and scalable production for pharma R&D and procurement.